pubmed-article:16150858 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16150858 | lifeskim:mentions | umls-concept:C0013072 | lld:lifeskim |
pubmed-article:16150858 | lifeskim:mentions | umls-concept:C0206677 | lld:lifeskim |
pubmed-article:16150858 | lifeskim:mentions | umls-concept:C0205422 | lld:lifeskim |
pubmed-article:16150858 | lifeskim:mentions | umls-concept:C0684321 | lld:lifeskim |
pubmed-article:16150858 | lifeskim:mentions | umls-concept:C2587213 | lld:lifeskim |
pubmed-article:16150858 | lifeskim:mentions | umls-concept:C1696465 | lld:lifeskim |
pubmed-article:16150858 | lifeskim:mentions | umls-concept:C0075616 | lld:lifeskim |
pubmed-article:16150858 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
pubmed-article:16150858 | lifeskim:mentions | umls-concept:C1704419 | lld:lifeskim |
pubmed-article:16150858 | lifeskim:mentions | umls-concept:C1407029 | lld:lifeskim |
pubmed-article:16150858 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:16150858 | pubmed:dateCreated | 2006-2-13 | lld:pubmed |
pubmed-article:16150858 | pubmed:abstractText | A 12 month, multicentre, randomised, double blind, placebo controlled, phase 3, dose-response study was carried out. Exisulind inhibits tumour growth by induction of apoptosis. The aim of our study was to investigate if exisulind induces regression of sporadic colonic adenomas. | lld:pubmed |
pubmed-article:16150858 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16150858 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16150858 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16150858 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16150858 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16150858 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16150858 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16150858 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16150858 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16150858 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16150858 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16150858 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16150858 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16150858 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16150858 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16150858 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16150858 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16150858 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16150858 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16150858 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16150858 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16150858 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16150858 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16150858 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16150858 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16150858 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16150858 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16150858 | pubmed:language | eng | lld:pubmed |
pubmed-article:16150858 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16150858 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:16150858 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16150858 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16150858 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16150858 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16150858 | pubmed:month | Mar | lld:pubmed |
pubmed-article:16150858 | pubmed:issn | 0017-5749 | lld:pubmed |
pubmed-article:16150858 | pubmed:author | pubmed-author:ReyGG | lld:pubmed |
pubmed-article:16150858 | pubmed:author | pubmed-author:HultcrantzRR | lld:pubmed |
pubmed-article:16150858 | pubmed:author | pubmed-author:KuwadaSS | lld:pubmed |
pubmed-article:16150858 | pubmed:author | pubmed-author:ArberNN | lld:pubmed |
pubmed-article:16150858 | pubmed:author | pubmed-author:LeshnoMM | lld:pubmed |
pubmed-article:16150858 | pubmed:author | pubmed-author:SjodahlRR | lld:pubmed |
pubmed-article:16150858 | pubmed:author | pubmed-author:Exisulind... | lld:pubmed |
pubmed-article:16150858 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16150858 | pubmed:volume | 55 | lld:pubmed |
pubmed-article:16150858 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16150858 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16150858 | pubmed:pagination | 367-73 | lld:pubmed |
pubmed-article:16150858 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
pubmed-article:16150858 | pubmed:meshHeading | pubmed-meshheading:16150858... | lld:pubmed |
pubmed-article:16150858 | pubmed:meshHeading | pubmed-meshheading:16150858... | lld:pubmed |
pubmed-article:16150858 | pubmed:meshHeading | pubmed-meshheading:16150858... | lld:pubmed |
pubmed-article:16150858 | pubmed:meshHeading | pubmed-meshheading:16150858... | lld:pubmed |
pubmed-article:16150858 | pubmed:meshHeading | pubmed-meshheading:16150858... | lld:pubmed |
pubmed-article:16150858 | pubmed:meshHeading | pubmed-meshheading:16150858... | lld:pubmed |
pubmed-article:16150858 | pubmed:meshHeading | pubmed-meshheading:16150858... | lld:pubmed |
pubmed-article:16150858 | pubmed:meshHeading | pubmed-meshheading:16150858... | lld:pubmed |
pubmed-article:16150858 | pubmed:meshHeading | pubmed-meshheading:16150858... | lld:pubmed |
pubmed-article:16150858 | pubmed:meshHeading | pubmed-meshheading:16150858... | lld:pubmed |
pubmed-article:16150858 | pubmed:meshHeading | pubmed-meshheading:16150858... | lld:pubmed |
pubmed-article:16150858 | pubmed:meshHeading | pubmed-meshheading:16150858... | lld:pubmed |
pubmed-article:16150858 | pubmed:meshHeading | pubmed-meshheading:16150858... | lld:pubmed |
pubmed-article:16150858 | pubmed:meshHeading | pubmed-meshheading:16150858... | lld:pubmed |
pubmed-article:16150858 | pubmed:meshHeading | pubmed-meshheading:16150858... | lld:pubmed |
pubmed-article:16150858 | pubmed:meshHeading | pubmed-meshheading:16150858... | lld:pubmed |
pubmed-article:16150858 | pubmed:year | 2006 | lld:pubmed |
pubmed-article:16150858 | pubmed:articleTitle | Sporadic adenomatous polyp regression with exisulind is effective but toxic: a randomised, double blind, placebo controlled, dose-response study. | lld:pubmed |
pubmed-article:16150858 | pubmed:affiliation | Integrated Comprehensive Cancer Prevention Center, Tel-Aviv Sourasky Medical Center, Tel-Aviv University, Israel. nadir@tasmc.health.gov.il | lld:pubmed |
pubmed-article:16150858 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16150858 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:16150858 | pubmed:publicationType | Multicenter Study | lld:pubmed |
pubmed-article:16150858 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16150858 | lld:pubmed |